➖ Institutional Placement Complete ➖
#Botanix has today announced that the Company has closed its A$13.5 million placement to new and existing institutional and sophisticated investors.
The proceeds from the Placement will be applied towards preparation for commercial launch activities of Sofpironium Bromide gel, 15% in the United States, as well as general working capital purposes and costs of the Placement.
Botanix Executive Chairman, Vince Ippolito, said:
“We are very pleased to finalise this Placement with the support of a number of new institutions and our committed investor base.
“There are a number of initiatives that need to be completed to ensure a successful launch of Sofdra™ and revenue growth, and this new capital enables those initiatives to be accelerated.”
Read today’s ASX release 👉 https://lnkd.in/gVTnfD-w
$BOT #ASX #health #biotech #medtech #research #innovation #dermatology #capitalraise #invest
Client Success Manager / Credit Lead at Nano Platform
3moSend us to the moon Graeme!